Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Allarity Therapeutics Inc ALLR

Healthcare Biotechnology
Allarity Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on developing personalized cancer treatments. The Company is focused on development of stenoparib, a poly-ADP-ribose polymerase/Tankyrase inhibitor for advanced ovarian cancer patients, using its DRP companion diagnostic for patient selection in the ongoing phase 2 clinical trial, NCT03878849. It has in-licensed the... see more

Recent & Breaking News (NDAQ:ALLR)

ALLR ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Allarity Therapeutics, Inc.

ACCESS Newswire July 30, 2024

INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Allarity Therapeutics, Inc. (ALLR) on Behalf of Investors

Business Wire July 30, 2024

ALLR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Allarity Therapeutics, Inc. and Encourages Shareholders to Contact the Firm!

ACCESS Newswire July 30, 2024

ALLR Investors Can Participate In The Allarity Therapeutics, Inc. Securities Fraud Investigation With The Schall Law Firm

ACCESS Newswire July 30, 2024

The Law Offices of Frank R. Cruz Continues Investigation of Allarity Therapeutics, Inc. (ALLR) on Behalf of Investors

Business Wire July 29, 2024

ATTENTION ALLR SHAREHOLDERS: Investors who lost money on Allarity Therapeutics, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation

ACCESS Newswire July 29, 2024

ALLR Investors Can Join The Allarity Therapeutics, Inc. Securities Fraud Investigation With The Schall Law Firm

ACCESS Newswire July 29, 2024

Investors who lost money on Allarity Therapeutics, Inc. should contact Levi & Korsinsky about an ongoing investigation - ALLR

ACCESS Newswire July 29, 2024

ALLR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Allarity Therapeutics, Inc. and Encourages Shareholders to Contact the Firm!

ACCESS Newswire July 29, 2024

Allarity Therapeutics, Inc. (ALLR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

Business Wire July 28, 2024

Levi & Korsinsky Investigates Possible Securities Fraud Violations by Allarity Therapeutics, Inc. (ALLR)

ACCESS Newswire July 28, 2024

Rosen Law Firm Encourages Allarity Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation - ALLR

PR Newswire July 28, 2024

ALLR STOCK ALERT: Levi & Korsinsky Notifies Allarity Therapeutics, Inc. Investors of an Ongoing Investigation

ACCESS Newswire July 28, 2024

ALLR STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Allarity Therapeutics, Inc. and Encourages Investors to Contact the Firm!

ACCESS Newswire July 28, 2024

Shareholders that lost money on Allarity Therapeutics, Inc.(ALLR) should contact Levi & Korsinsky about Securities Fraud Investigation - ALLR

ACCESS Newswire July 28, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Allarity Therapeutics, Inc. - ALLR

Newsfile July 28, 2024

ALLR ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Allarity Therapeutics, Inc. Shareholders Who Lost Money

ACCESS Newswire July 27, 2024

Allarity Therapeutics, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details- ALLR

ACCESS Newswire July 26, 2024

Shareholders that lost money on Allarity Therapeutics, Inc. (ALLR) should contact Levi & Korsinsky about Securities Fraud Investigation - ALLR

ACCESS Newswire July 26, 2024

ALLR Investors Can Participate In The Allarity Therapeutics, Inc. Securities Fraud Investigation With The Schall Law Firm

ACCESS Newswire July 26, 2024